Tourmaline Bio Net Income
| TRMLDelisted Stock | 47.98 0.00 0.00% |
As of the 11th of February 2026, Tourmaline Bio has the Downside Deviation of 1.82, risk adjusted performance of 0.149, and Standard Deviation of 7.46. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tourmaline Bio, as well as the relationship between them. Please validate Tourmaline Bio treynor ratio and semi variance to decide if Tourmaline Bio is priced more or less accurately, providing market reflects its prevalent price of 47.98 per share. Given that Tourmaline Bio has treynor ratio of (1.75), we advise you to double-check Tourmaline Bio's current market performance to make sure the company can sustain itself at a future point.
Tourmaline Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tourmaline Bio's valuation are provided below:Tourmaline Bio does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Tourmaline |
Search Suggestions
| TR | Tootsie Roll Industries | Company |
| TRTN-PC | Triton International Limited | Company |
| TRBCX | T Rowe Price | Mutual Fund |
| TRBF | Angel Oak Total | ETF |
| TRIN | NYSE Trin Index | Index |
| TRB | TRB | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Tourmaline Bio reported net income of (73.21 Million). This is 121.45% lower than that of the Biotechnology sector and 204.52% lower than that of the Health Care industry. The net income for all United States stocks is 112.82% higher than that of the company.
Tourmaline Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tourmaline Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tourmaline Bio could also be used in its relative valuation, which is a method of valuing Tourmaline Bio by comparing valuation metrics of similar companies.Tourmaline Bio is currently under evaluation in net income category among its peers.
Tourmaline Fundamentals
| Return On Equity | -0.3 | |||
| Return On Asset | -0.21 | |||
| Current Valuation | 993.63 M | |||
| Shares Outstanding | 25.69 M | |||
| Shares Owned By Insiders | 14.62 % | |||
| Shares Owned By Institutions | 89.12 % | |||
| Number Of Shares Shorted | 808.96 K | |||
| Price To Book | 4.75 X | |||
| EBITDA | (89.73 M) | |||
| Net Income | (73.21 M) | |||
| Total Debt | 244 K | |||
| Book Value Per Share | 10.09 X | |||
| Cash Flow From Operations | (77.26 M) | |||
| Short Ratio | 1.12 X | |||
| Earnings Per Share | (3.44) X | |||
| Target Price | 48.0 | |||
| Number Of Employees | 76 | |||
| Beta | 1.58 | |||
| Market Capitalization | 1.23 B | |||
| Total Asset | 309 M | |||
| Retained Earnings | (135.26 M) | |||
| Working Capital | 259.93 M | |||
| Net Asset | 309 M |
About Tourmaline Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tourmaline Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tourmaline Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tourmaline Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Tourmaline Stock
If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |